PPD Announces Third Quarter 2021 Earnings Conference Call
18 Ottobre 2021 - 10:05PM
Business Wire
PPD, Inc. (Nasdaq: PPD), a leading global contract research
organization, will host a conference call on Thursday, October 28,
2021, at 8 a.m. (U.S. Eastern Time) to discuss its third quarter
2021 financial results. Investors and other interested parties may
listen to a live webcast of the conference call by logging on to
the investors section of PPD’s website at
https://investors.ppd.com. An archived copy of the webcast will be
available on the website after the call.
In addition, the conference call can be accessed live over the
phone by dialing +1 877 407 0784, or for international callers, +1
201 689 8560. A replay will be available after the call and can be
accessed by dialing +1 844 512 2921, or for international callers,
+1 412 317 6671. The passcode for the live conference call and the
replay is 13724407. The audio replay will be available until
Thursday, November 11, 2021. Due to the proposed merger with Thermo
Fisher Scientific Inc. previously announced on April 15, 2021,
which is subject to regulatory approvals in addition to the
satisfaction of customary closing conditions, there will be no
opportunity to ask questions on the conference call.
About PPD
PPD is a leading global contract research organization providing
comprehensive, integrated drug development, laboratory and
lifecycle management services. Our customers and partners include
pharmaceutical, biotechnology, medical device, academic and
government organizations. With more than 30,000 professionals
worldwide, PPD has conducted clinical trials in more than 100
countries to help customers deliver life-changing therapies to
improve health. We apply innovative technologies, therapeutic
expertise and a firm commitment to quality to bend the cost and
time curve of drug development and optimize value. For more
information, visit www.ppd.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211018005958/en/
Investors: Tracy Krumme +1 910 558 4186 investors@ppd.com
Media: media@ppd.com
Grafico Azioni Pharmaceutical Product Developme (NASDAQ:PPDI)
Storico
Da Set 2024 a Ott 2024
Grafico Azioni Pharmaceutical Product Developme (NASDAQ:PPDI)
Storico
Da Ott 2023 a Ott 2024
Notizie in Tempo Reale relative a Pharmaceutical Prod Dev (MM) (NASDAQ): 0 articoli recenti
Più Pharmaceutical Prod Dev (MM) Articoli Notizie